Showing 1,941 - 1,960 results of 2,482 for search '"hepatitis"', query time: 0.05s Refine Results
  1. 1941

    Modern treatment methods of patients with liver metastases of colorectal cancer by Ye. N. Grebenkin, V. D. Chhikvadze, U. S. Stanoyevich, Ye. I. Dekhissi

    Published 2013-07-01
    “…Efficacy of liver resection, radio-frequency ablation (RFA), systemic and intra-arterial hepatic chemotherapy (IAHC) was studied.Results. The five-years general survival rate at liver resection was 33,3%, relapse-free – 22,2%, at RFA – 16,2 and 13,5% respectively. …”
    Get full text
    Article
  2. 1942

    Isolated Gastrointestinal Metastasis of Breast Carcinoma: A Case Report by M. A. Titi, A. Anabtawi, A. D. Newland

    Published 2010-01-01
    “…She had breast carcinoma treated 7 years previously with normal follow-up since. Colonoscopy showed hepatic flexure thickening that was confirmed to be breast metastasis. …”
    Get full text
    Article
  3. 1943

    Nonfatal Hyperammonemic Encephalopathy as a Late Complication of Roux-en-Y Gastric Bypass by Juan D. Salcedo, Jordan S. Goldstein, Jose M. Quinonez, Maria Antonietta Mosetti

    Published 2019-01-01
    “…Hyperammonemic encephalopathy in the absence of known hepatic dysfunction presents a diagnostic dilemma. …”
    Get full text
    Article
  4. 1944

    Bacillus cereus Typhlitis in a Patient with Acute Myelogenous Leukemia: A Case Report and Review of the Literature by James D. Denham, Sowmya Nanjappa, John N. Greene

    Published 2018-01-01
    “…Individual case reports and case series exist in the literature describing various clinical manifestations of B. cereus in the neutropenic patient including bacteremia/septicemia, pneumonia, meningitis/encephalitis, hepatic abscesses, and gastritis. In this report, we describe a case of typhlitis caused by B. cereus in a 74-year-old female with recently diagnosed acute myelogenous leukemia (AML), and we summarize the available English language literature to draw tentative conclusions regarding the clinical manifestations of this organism.…”
    Get full text
    Article
  5. 1945

    Growth Hormone and Reproduction: A Review of Endocrine and Autocrine/Paracrine Interactions by Kerry L. Hull, Steve Harvey

    Published 2014-01-01
    “…The somatotropic axis, consisting of growth hormone (GH), hepatic insulin-like growth factor I (IGF-I), and assorted releasing factors, regulates growth and body composition. …”
    Get full text
    Article
  6. 1946

    Synthesis and Evaluation of Some New Isoquine Analogues for Antimalarial Activity by Chandra Nath Saha, Sanjib Bhattacharya, Dipak Chetia

    Published 2009-01-01
    “…Amodiaquine is a 4-aminoquinoline antimalarial that can cause adverse side effects including hepatic and haematological toxicity. The drug toxicity involves the formation of an electrophilic metabolite, amodiaquine quinoneimine (AQQI), which binds to cellular macromolecules leading to hepatotoxicity and agranulocytosis. …”
    Get full text
    Article
  7. 1947

    Protective effect of brain and muscle arnt-like protein-1 against ethanol-induced ferroptosis by activating Nrf2 in mice liver and HepG2 cells by Yanan Zhao, Ranran Zhang, Ziheng Chen, Ziyi Wang, Shuang Guan, Jing Lu

    Published 2023-11-01
    “…Collectively, our results unveiled that the protective action of BMAL1 during alcohol challenge depends on its ability to activate Nrf2-ARE antiferroptosis pathway and targeting hepatic BMAL1 to dampen hepatic ferroptosis signaling may have therapeutic potential for ALD.…”
    Get full text
    Article
  8. 1948

    Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin by Hamad Abdulsalam Hamad Alfarisi, Muhammad Bin Ibrahim, Zenab B. Hamad Mohamed, Nuraniza Azahari, Asmah Hanim Bt. Hamdan, Che Anuar Che Mohamad

    Published 2020-01-01
    “…Trihoney and atorvastatin showed marked (p<0.001) reduction of hepatic lipid peroxidation. Trihoney showed histological protection against progression of NAFLD to nonalcoholic steatohepatitis (NASH). …”
    Get full text
    Article
  9. 1949

    Calcium hydroxide nanoparticles induce cell death, genomic instability, oxidative stress and apoptotic gene dysregulation on human HepG2 cells by Hanan R. H. Mohamed, Esraa H. Ibrahim, Shahd E. E. Shaheen, Nesma O. E. Hussein, Ayman Diab, Gehan Safwat

    Published 2025-01-01
    “…Further studies are required to explore the biological and toxicological properties and therapeutic potential of Ca(OH)2NPs in hepatic cancer treatment.…”
    Get full text
    Article
  10. 1950

    Effect of soluble dietary fiber extracted from Lentinula edodes (Berk.) Pegler on lipid metabolism and liver protection in mice on high-fat diet by Kangxiao Guo, Kangxiao Guo, Jing Liu, Zihan Yao, Zhoujin Tan, Tao Yang

    Published 2025-01-01
    “…After 4 weeks, we assessed general state, organ conditions, liver status, blood parameters, expression of hepatic lipid metabolism genes, mRNA levels of key hepatic lipid metabolism genes. …”
    Get full text
    Article
  11. 1951

    Case report: A study on the pathological diagnosis of oral fibrosarcoma in a giant panda by Zongliang Xiong, Shanshan Ling, Caiwu Li, Linhua Deng, Ming He, Chengdong Wang, Desheng Li, Zhengli Chen

    Published 2025-02-01
    “…Hematological tests revealed elevated levels of the tumor marker CA724, along with infectious disease, anemia, hepatic damage, and renal failure. Imaging studies identified a soft tissue mass in the right cheek area. …”
    Get full text
    Article
  12. 1952

    Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives by Siyuan Yang, Yunyi Zou, Chunhua Zhong, Zuoqiong Zhou, Xiyang Peng, Changfa Tang

    Published 2025-01-01
    “…Conversely, excessive pyroptosis intensifies inflammatory responses, exacerbates hepatocyte damage and promotes the activation and proliferation of hepatic stellate cells, accelerating liver fibrosis. …”
    Get full text
    Article
  13. 1953

    The Successful Use of Inhaled Nitric Oxide in the Management of Severe Hepatopulmonary Syndrome after Orthotopic Liver Transplantation by Joshua Santos, Philip Young, Igor Barjaktarevic, Catherine Lazar, Irawan Susanto, Tisha Wang

    Published 2014-01-01
    “…Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and subsequent hypoxemia in the setting of hepatic dysfunction. There is currently no pharmacologic intervention that has been shown to significantly affect outcomes and liver transplantation remains the mainstay of therapy. …”
    Get full text
    Article
  14. 1954

    Raoultella Planticola Bacteremia Following Consumption of Seafood by Philip W Lam, Irving E Salit

    Published 2014-01-01
    “…Recent chemotherapy, proton pump inhibitor use and altered biliary flow secondary to hepatic metastases may have been contributing factors to the pathogenesis of disease.…”
    Get full text
    Article
  15. 1955

    Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis by Stefania Bruno, Maria Beatriz Herrera Sanchez, Chiara Pasquino, Marta Tapparo, Massimo Cedrino, Ciro Tetta, Giovanni Camussi

    Published 2019-01-01
    “…In addition, HLSCs show a specific commitment to the hepatic phenotype. Injection of HLSCs into immunodeficient mice fed with a methionine-choline-deficient diet to induce nonalcoholic steatohepatitis ameliorates liver function and morphology. …”
    Get full text
    Article
  16. 1956

    Is There a Role for Probiotics in Liver Disease? by Robert S. Lo, Andrew S. Austin, Jan G. Freeman

    Published 2014-01-01
    “…There is mounting evidence that probiotics are effective in the treatment of covert and overt hepatic encephalopathy, as well as in the prevention of recurrence of encephalopathy. …”
    Get full text
    Article
  17. 1957

    Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis by D. V. Garbuzenko

    Published 2012-04-01
    “…Gastroduodenoscopy and hepatic venous pressure gradient measurement remain to be the standard methods of screening diagnostics of patients with liver cirrhosis for estimation of VEV bleeding risk nowadays. …”
    Get full text
    Article
  18. 1958
  19. 1959

    FIRST RUSSIAN EXPERIENCE OF USING THE INTEGRATED SYSTEM OF LASER THERMOABLATION THERAPY IN THE TREATMENT OF METASTATIC LIVER CANCER by D. V. Sidorov, S. O. Stepanov, M. V. Lozhkin, L. O. Petrov, O. V. Gutz, A. A. Kostin, A. G. Isaeva

    Published 2017-09-01
    “…In patients with a reduced functional reserve of the liver or a missing volume of the remaining liver parenchyma, these interventions become impossible because of the increased risk of postresectional acute hepatic insufficiency. One of the most modern and promising ways to overcome this obstacle is the use of minimally invasive methods of tumor destruction. …”
    Get full text
    Article
  20. 1960

    Systemic and Local CC Chemokines Production in a Murine Model of Listeria monocytogenes Infection by Marina Bubonja, Branka Wraber, Gordana Brumini, Ivana Gobin, Danijela Veljkovic, Maja Abram

    Published 2006-01-01
    “…Repeated intragastric inoculation of Listeria monocytogenes into BALB/c mice resulted in prolonged bacteraemia and severe hepatic infection. Bacteria could also be isolated from the brain tissue of all experimental mice. …”
    Get full text
    Article